Condition
HIV Disease Progression
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Enrolling By Invitation1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05584397Enrolling By Invitation
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART
NCT05580666Phase 3RecruitingPrimary
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
NCT05383456Completed
The Visceral Adiposity Measurement and Observation Study
NCT05688709Not ApplicableUnknownPrimary
Acceptability, Feasibility and Effectiveness of Online Peer Support Group for ART Adherence Among Youth
NCT01299948Phase 2CompletedPrimary
Progression of HIV-Disease Under Low Dose Corticosteroids
Showing all 5 trials